Stay updated on ARO-APOC3 in FCS Clinical Trial

Sign up to get notified when there's something new on the ARO-APOC3 in FCS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-APOC3 in FCS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional publications related to drug safety and specific medical conditions. Notably, the drug 'plozasiran' is highlighted, indicating a focus on its management of certain diseases.
    Difference
    18%
    Check dated 2025-08-30T12:05:31.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:44:48.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T00:14:48.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-01T19:32:49.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-07-25T15:05:11.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-18T11:51:58.000Z thumbnail image

Stay in the know with updates to ARO-APOC3 in FCS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in FCS Clinical Trial page.